img

Global Vasculitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vasculitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vasculitis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vasculitis Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Polyarteritis Nodosa and Thrombotic Vasculitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vasculitis Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vasculitis Drug key manufacturers include Merck, Bayer, Farmalider, Hainan Pharmaceutical Factory, Shanghaihuangxiang Lantian Pharmaceutical, Huzhou Konch Pharmaceutical, CSPC Ouyi Pharmaceutical, Sino-US Zibo Xinhua-Perrigo Pharmaceutical and Hubei Biocause Pharmaceutical, etc. Merck, Bayer, Farmalider are top 3 players and held % sales share in total in 2022.
Vasculitis Drug can be divided into Blisibimod, CCX-168, Gevokizumab and Rituximab Biosimilar, etc. Blisibimod is the mainstream product in the market, accounting for % sales share globally in 2022.
Vasculitis Drug is widely used in various fields, such as Polyarteritis Nodosa, Thrombotic Vasculitis, Granulomatous Vasculitis and Lymphocytic Vasculitis, etc. Polyarteritis Nodosa provides greatest supports to the Vasculitis Drug industry development. In 2022, global % sales of Vasculitis Drug went into Polyarteritis Nodosa filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vasculitis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Bayer
Farmalider
Hainan Pharmaceutical Factory
Shanghaihuangxiang Lantian Pharmaceutical
Huzhou Konch Pharmaceutical
CSPC Ouyi Pharmaceutical
Sino-US Zibo Xinhua-Perrigo Pharmaceutical
Hubei Biocause Pharmaceutical
Segment by Type
Blisibimod
CCX-168
Gevokizumab
Rituximab Biosimilar
Others

Segment by Application


Polyarteritis Nodosa
Thrombotic Vasculitis
Granulomatous Vasculitis
Lymphocytic Vasculitis
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vasculitis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vasculitis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vasculitis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vasculitis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vasculitis Drug introduction, etc. Vasculitis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Vasculitis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Vasculitis Drug Market Overview
1.1 Vasculitis Drug Product Overview
1.2 Vasculitis Drug Market Segment by Type
1.2.1 Blisibimod
1.2.2 CCX-168
1.2.3 Gevokizumab
1.2.4 Rituximab Biosimilar
1.2.5 Others
1.3 Global Vasculitis Drug Market Size by Type
1.3.1 Global Vasculitis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Vasculitis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vasculitis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vasculitis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vasculitis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vasculitis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vasculitis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vasculitis Drug Sales Breakdown by Type (2018-2024)
2 Global Vasculitis Drug Market Competition by Company
2.1 Global Top Players by Vasculitis Drug Sales (2018-2024)
2.2 Global Top Players by Vasculitis Drug Revenue (2018-2024)
2.3 Global Top Players by Vasculitis Drug Price (2018-2024)
2.4 Global Top Manufacturers Vasculitis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vasculitis Drug Market Competitive Situation and Trends
2.5.1 Vasculitis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vasculitis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vasculitis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Vasculitis Drug Market
2.8 Key Manufacturers Vasculitis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vasculitis Drug Status and Outlook by Region
3.1 Global Vasculitis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Vasculitis Drug Historic Market Size by Region
3.2.1 Global Vasculitis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Vasculitis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Vasculitis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vasculitis Drug Forecasted Market Size by Region
3.3.1 Global Vasculitis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Vasculitis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Vasculitis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vasculitis Drug by Application
4.1 Vasculitis Drug Market Segment by Application
4.1.1 Polyarteritis Nodosa
4.1.2 Thrombotic Vasculitis
4.1.3 Granulomatous Vasculitis
4.1.4 Lymphocytic Vasculitis
4.1.5 Others
4.2 Global Vasculitis Drug Market Size by Application
4.2.1 Global Vasculitis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Vasculitis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vasculitis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vasculitis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vasculitis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vasculitis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vasculitis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vasculitis Drug Sales Breakdown by Application (2018-2024)
5 North America Vasculitis Drug by Country
5.1 North America Vasculitis Drug Historic Market Size by Country
5.1.1 North America Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Vasculitis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Vasculitis Drug Sales in Value by Country (2018-2024)
5.2 North America Vasculitis Drug Forecasted Market Size by Country
5.2.1 North America Vasculitis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Vasculitis Drug Sales in Value by Country (2024-2034)
6 Europe Vasculitis Drug by Country
6.1 Europe Vasculitis Drug Historic Market Size by Country
6.1.1 Europe Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Vasculitis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Vasculitis Drug Sales in Value by Country (2018-2024)
6.2 Europe Vasculitis Drug Forecasted Market Size by Country
6.2.1 Europe Vasculitis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Vasculitis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Vasculitis Drug by Region
7.1 Asia-Pacific Vasculitis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Vasculitis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Vasculitis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vasculitis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vasculitis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Vasculitis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vasculitis Drug Sales in Value by Region (2024-2034)
8 Latin America Vasculitis Drug by Country
8.1 Latin America Vasculitis Drug Historic Market Size by Country
8.1.1 Latin America Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Vasculitis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vasculitis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Vasculitis Drug Forecasted Market Size by Country
8.2.1 Latin America Vasculitis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vasculitis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Vasculitis Drug by Country
9.1 Middle East and Africa Vasculitis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Vasculitis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vasculitis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vasculitis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Vasculitis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vasculitis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Vasculitis Drug Products Offered
10.1.5 Merck Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Vasculitis Drug Products Offered
10.2.5 Bayer Recent Development
10.3 Farmalider
10.3.1 Farmalider Company Information
10.3.2 Farmalider Introduction and Business Overview
10.3.3 Farmalider Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Farmalider Vasculitis Drug Products Offered
10.3.5 Farmalider Recent Development
10.4 Hainan Pharmaceutical Factory
10.4.1 Hainan Pharmaceutical Factory Company Information
10.4.2 Hainan Pharmaceutical Factory Introduction and Business Overview
10.4.3 Hainan Pharmaceutical Factory Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hainan Pharmaceutical Factory Vasculitis Drug Products Offered
10.4.5 Hainan Pharmaceutical Factory Recent Development
10.5 Shanghaihuangxiang Lantian Pharmaceutical
10.5.1 Shanghaihuangxiang Lantian Pharmaceutical Company Information
10.5.2 Shanghaihuangxiang Lantian Pharmaceutical Introduction and Business Overview
10.5.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Products Offered
10.5.5 Shanghaihuangxiang Lantian Pharmaceutical Recent Development
10.6 Huzhou Konch Pharmaceutical
10.6.1 Huzhou Konch Pharmaceutical Company Information
10.6.2 Huzhou Konch Pharmaceutical Introduction and Business Overview
10.6.3 Huzhou Konch Pharmaceutical Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Huzhou Konch Pharmaceutical Vasculitis Drug Products Offered
10.6.5 Huzhou Konch Pharmaceutical Recent Development
10.7 CSPC Ouyi Pharmaceutical
10.7.1 CSPC Ouyi Pharmaceutical Company Information
10.7.2 CSPC Ouyi Pharmaceutical Introduction and Business Overview
10.7.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 CSPC Ouyi Pharmaceutical Vasculitis Drug Products Offered
10.7.5 CSPC Ouyi Pharmaceutical Recent Development
10.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
10.8.1 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Company Information
10.8.2 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Introduction and Business Overview
10.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Products Offered
10.8.5 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Development
10.9 Hubei Biocause Pharmaceutical
10.9.1 Hubei Biocause Pharmaceutical Company Information
10.9.2 Hubei Biocause Pharmaceutical Introduction and Business Overview
10.9.3 Hubei Biocause Pharmaceutical Vasculitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Hubei Biocause Pharmaceutical Vasculitis Drug Products Offered
10.9.5 Hubei Biocause Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vasculitis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vasculitis Drug Industrial Chain Analysis
11.4 Vasculitis Drug Market Dynamics
11.4.1 Vasculitis Drug Industry Trends
11.4.2 Vasculitis Drug Market Drivers
11.4.3 Vasculitis Drug Market Challenges
11.4.4 Vasculitis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vasculitis Drug Distributors
12.3 Vasculitis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Blisibimod
Table 2. Major Company of CCX-168
Table 3. Major Company of Gevokizumab
Table 4. Major Company of Rituximab Biosimilar
Table 5. Major Company of Others
Table 6. Global Vasculitis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Vasculitis Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Vasculitis Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Vasculitis Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Vasculitis Drug Market Share in Value by Type (2018-2024)
Table 11. Global Vasculitis Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Vasculitis Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Vasculitis Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Vasculitis Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Vasculitis Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Vasculitis Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Vasculitis Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Vasculitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Vasculitis Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Vasculitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Vasculitis Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Vasculitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Vasculitis Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Vasculitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Vasculitis Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Vasculitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Vasculitis Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Vasculitis Drug Sales Share by Company (2018-2024)
Table 29. Global Vasculitis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Vasculitis Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Vasculitis Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Vasculitis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Vasculitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vasculitis Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Vasculitis Drug Market
Table 36. Key Manufacturers Vasculitis Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Vasculitis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Vasculitis Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Vasculitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Vasculitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Vasculitis Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Vasculitis Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Vasculitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Vasculitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Vasculitis Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Vasculitis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Vasculitis Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Vasculitis Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Vasculitis Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Vasculitis Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Vasculitis Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Vasculitis Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Vasculitis Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Vasculitis Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Vasculitis Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Vasculitis Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Vasculitis Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Vasculitis Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Vasculitis Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Vasculitis Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Vasculitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Vasculitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Vasculitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Vasculitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Vasculitis Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Vasculitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Vasculitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Vasculitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Vasculitis Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Vasculitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Vasculitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Vasculitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Vasculitis Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Vasculitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Vasculitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Vasculitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Vasculitis Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Vasculitis Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Vasculitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Vasculitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Vasculitis Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Vasculitis Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Vasculitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Vasculitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Vasculitis Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Vasculitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Vasculitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Vasculitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Vasculitis Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Vasculitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Vasculitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Vasculitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Vasculitis Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Vasculitis Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Vasculitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Vasculitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Vasculitis Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Vasculitis Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Vasculitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Vasculitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Vasculitis Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Merck Company Information
Table 111. Merck Introduction and Business Overview
Table 112. Merck Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Merck Vasculitis Drug Product
Table 114. Merck Recent Development
Table 115. Bayer Company Information
Table 116. Bayer Introduction and Business Overview
Table 117. Bayer Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Bayer Vasculitis Drug Product
Table 119. Bayer Recent Development
Table 120. Farmalider Company Information
Table 121. Farmalider Introduction and Business Overview
Table 122. Farmalider Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Farmalider Vasculitis Drug Product
Table 124. Farmalider Recent Development
Table 125. Hainan Pharmaceutical Factory Company Information
Table 126. Hainan Pharmaceutical Factory Introduction and Business Overview
Table 127. Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Hainan Pharmaceutical Factory Vasculitis Drug Product
Table 129. Hainan Pharmaceutical Factory Recent Development
Table 130. Shanghaihuangxiang Lantian Pharmaceutical Company Information
Table 131. Shanghaihuangxiang Lantian Pharmaceutical Introduction and Business Overview
Table 132. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Product
Table 134. Shanghaihuangxiang Lantian Pharmaceutical Recent Development
Table 135. Huzhou Konch Pharmaceutical Company Information
Table 136. Huzhou Konch Pharmaceutical Introduction and Business Overview
Table 137. Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Huzhou Konch Pharmaceutical Vasculitis Drug Product
Table 139. Huzhou Konch Pharmaceutical Recent Development
Table 140. CSPC Ouyi Pharmaceutical Company Information
Table 141. CSPC Ouyi Pharmaceutical Introduction and Business Overview
Table 142. CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. CSPC Ouyi Pharmaceutical Vasculitis Drug Product
Table 144. CSPC Ouyi Pharmaceutical Recent Development
Table 145. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Company Information
Table 146. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Introduction and Business Overview
Table 147. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Product
Table 149. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Development
Table 150. Hubei Biocause Pharmaceutical Company Information
Table 151. Hubei Biocause Pharmaceutical Introduction and Business Overview
Table 152. Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Hubei Biocause Pharmaceutical Vasculitis Drug Product
Table 154. Hubei Biocause Pharmaceutical Recent Development
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Vasculitis Drug Market Trends
Table 158. Vasculitis Drug Market Drivers
Table 159. Vasculitis Drug Market Challenges
Table 160. Vasculitis Drug Market Restraints
Table 161. Vasculitis Drug Distributors List
Table 162. Vasculitis Drug Downstream Customers
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Vasculitis Drug Product Picture
Figure 2. Global Vasculitis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vasculitis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Vasculitis Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Blisibimod
Figure 6. Global Blisibimod Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CCX-168
Figure 8. Global CCX-168 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Gevokizumab
Figure 10. Global Gevokizumab Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Rituximab Biosimilar
Figure 12. Global Rituximab Biosimilar Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Vasculitis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Vasculitis Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Vasculitis Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Vasculitis Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Vasculitis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Vasculitis Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Vasculitis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Vasculitis Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Vasculitis Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Vasculitis Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Vasculitis Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Vasculitis Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Vasculitis Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Vasculitis Drug Revenue in 2022
Figure 29. Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Polyarteritis Nodosa
Figure 31. Global Polyarteritis Nodosa Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Thrombotic Vasculitis
Figure 33. Global Thrombotic Vasculitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Granulomatous Vasculitis
Figure 35. Global Granulomatous Vasculitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Lymphocytic Vasculitis
Figure 37. Global Lymphocytic Vasculitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Vasculitis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Vasculitis Drug Sales Market Share by Application in 2022 & 2034
Figure 42. North America Vasculitis Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Vasculitis Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Vasculitis Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Vasculitis Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Vasculitis Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Vasculitis Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Vasculitis Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Vasculitis Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Vasculitis Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Vasculitis Drug Manufacturing Cost Structure
Figure 53. Vasculitis Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries